Clareo Health | Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
Diagnosed with (at least) one of the following autoimmune diseases:
* Rheumatoid arthritis (RA) according to the 2010 EULAR/ACR classification criteria,
* Gout according to the 2015 EULAR/ACR classification criteria,
* Systemic lupus erythematosus according to the 2019 EULAR/ACR classification criteria
* Sjogren's Syndrome according to the 2016 EULAR/ACR classification criteria
According to local regulations, patient has expressed his/her non-opposition (for France) or has provided written informed consent (for Switzerland and Germany) to participate in the study
Patient has access to the internet, a functioning email address and a mobile phone number
Patient physically and mentally able to use a computer tool connected to the Internet
Only in Switzerland \& Germany : patient is covered by a health insurance plan
You may not be if
Any neurodegenerative disease that alters cognitive faculties
Refractory cancer
Patients who do not have access to the Internet and/or do not master its use in the context of this protocol
Unwillingness or inability to adhere to study protocol (language barriers, cognitive disorders…) Subject who is compulsorily detained for psychiatric treatment
Patient who cannot be followed for 2 years by the investigating physician
Patient over the age of legal majority who is protected, or deprived of liberty by judicial or administrative decision (vulnerable subject)
Patient with an estimated life expectancy shorter than 1 year
